Artesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria Treatment

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: Injection
Still deciding? Get samples of $ !
Request Sample
Gold Member Since 2017

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, ISO 9000, GMP, HACCP, BREEAM
Export Year
2016-07-01
  • Artesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria Treatment
  • Artesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria Treatment
  • Artesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria Treatment
  • Artesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria Treatment
  • Artesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria Treatment
  • Artesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria Treatment
Find Similar Products

Basic Info.

Model NO.
z24
Suitable for
Elderly, Children, Adult
State
Liquid
Shape
Injection
Type
Inorganic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
Z02
Drug Ad Approval No.
Z02
Transport Package
Ampoules
Specification
2ml 10ml
Trademark
Sinopharmatech
Origin
Shandong, China
HS Code
30049090
Production Capacity
5000000 Pieces/Month

Product Description

 

Overview:
Artesunate 80mg/ml, with 80mg of Artesunate per ml, is a highly effective solution for the treatment of malaria. Known for its rapid action against the malaria parasite, this medication is trusted by healthcare professionals worldwide to combat severe malaria cases. Whether used in emergency treatments or standard malaria management, Artesunate 80mg/ml offers fast relief, reducing the symptoms of malaria quickly and efficiently.

Key Specifications:

  • Active Ingredient: Artesunate 80mg per vial (lyophilized powder)

  • Therapeutic Class: Antimalarial (Artemisinin derivative)

  • Indications:

    • First-line therapy for severe Plasmodium falciparum malaria

    • Cerebral malaria cases

  • Administration: IV/IM after reconstitution with provided diluent

  • Compliance: Manufactured under WHO-GMP standards

  • Packaging: Single-dose vial + 1ml sodium bicarbonate solvent

  • Storage: Stable below 30°C (protect from light)

Key Features:
   •     Active Ingredient: Artesunate 80mg/ml
   •     High Efficacy: Rapidly targets and eliminates malaria parasites
   •     Quick Relief: Works quickly to reduce symptoms and improve patient condition
   •     For Severe Cases: Widely used in severe and emergency malaria treatments
   •     Safe and Reliable: Trusted by medical professionals for effective malaria control

 
Active Ingredient Artesunate
Dosage Form Injection iv/im
Strength 80 mg per vial
Manufacturer Sinopharmatech Co., Ltd.

Available in various packaging options, customisable based on market requirements.

For more details or to request samples, please contact our sales representatives!

Artesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria TreatmentArtesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria TreatmentArtesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria TreatmentArtesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria TreatmentArtesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria TreatmentArtesunate 80mg – Antimalarial Injection/Vial (WHO Prequalified) – Severe Malaria Treatment

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier